OT
Healthcare & Life Sciences
Orbital Therapeutics
Orbital Therapeutics is a Healthcare & Life Sciences startup, since acquired, 1 tracked investor.
Acquiredacquired
acquired
Stage
1
Investors
About Orbital Therapeutics
Orbital Therapeutics is a startup. Orbital Therapeutics has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Orbital Therapeutics was a preclinical company developing next-generation therapies and vaccines using a circular RNA (circRNA) platform targeting rare diseases, oncology, and immunology, before being acquired by Bristol Myers Squibb for $1.5 billion.
Explore Orbital Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.